Enrique Conterno

(Mr. Enrique Conterno)

Currently holds a position at FibroGen Inc

Positions

Position Company Period
Chief Executive Officer, Director FibroGen Inc Jan. 6, 2020 -
Senior Vice President and President - Lilly Diabetes and President - Lilly USA Eli Lilly and Co Feb. 1, 2017 - Dec. 31, 2019
Senior Vice President and President - Lilly Diabetes Eli Lilly and Co Nov. 1, 2009 - Feb. 1, 2017
Enrique Conterno's trades of FibroGen Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-10 2023-07-07
US FibroGen Inc (FGEN)
S Sale
1,880 -0.5%
2.80
USD 5,264 		1,880 -0.5% 2.80 USD 5,264
2023-06-09 2023-06-07
US FibroGen Inc (FGEN)
S Sale
6,106 -1.6%
17.04
USD 104,033 		6,106 -1.6% 17.04 USD 104,033
2023-06-09 2023-06-07
US FibroGen Inc (FGEN)
PS Planned sale
2,791 -0.7%
17.04
USD 47,550 		2,791 -0.7% 17.04 USD 47,550
2023-04-11 2023-04-10
US FibroGen Inc (FGEN)
S Sale
1,869 -0.5%
19.52
USD 36,483 		1,869 -0.5% 19.52 USD 36,483
2023-03-10 2023-03-10
US FibroGen Inc (FGEN)
S Sale
19,486 -4.8%
20.20
USD 393,565 		19,486 -4.8% 20.20 USD 393,565
2023-03-10 2023-03-10
US FibroGen Inc (FGEN)
S Sale
12,103 -2.9%
20.20
USD 244,448 		12,103 -2.9% 20.20 USD 244,448
2023-03-10 2023-03-08
US FibroGen Inc (FGEN)
S Sale
24,672 -6.5%
21.16
USD 521,958 		24,672 -6.5% 21.16 USD 521,958
2023-01-10 2023-01-06
US FibroGen Inc (FGEN)
PS Planned sale
1,538 -0.5%
19.95
USD 30,683 		1,538 -0.5% 19.95 USD 30,683
2022-12-09 2022-12-08
US FibroGen Inc (FGEN)
S Sale
2,543 -0.8%
15.79
USD 40,154 		2,543 -0.8% 15.79 USD 40,154
2020-06-12 2020-06-11
US FibroGen Inc (FGEN)
B Purchase
19,800 +247.5%
35.28
USD 698,599 		19,800 +247.5% 35.28 USD 698,599
2020-06-12 2020-06-10
US FibroGen Inc (FGEN)
B Purchase
8,000 +inf%
36.29
USD 290,282 		8,000 +inf% 36.29 USD 290,282
2019-02-20 2019-02-15
PS Planned sale
25,000 -15.8%
121.00
USD 3,025,000 		25,000 -15.8% 121.00 USD 3,025,000
// ... existing code ... // ... rest of the file ...